Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -2.69%1.35B | -13.12%726.04M | -22.12%1.39B | -12.36%835.66M | 13.87%1.78B | 21.96%953.48M | 37.03%1.56B | 63.76%781.76M | 47.73%1.14B | 23.30%477.39M |
| Operating income | -2.69%1.35B | -13.12%726.04M | -22.12%1.39B | -12.36%835.66M | 13.87%1.78B | 21.96%953.48M | 37.03%1.56B | 63.76%781.76M | 47.73%1.14B | 23.30%477.39M |
| Cost of sales | 14.34%-647.98M | 3.55%-407.69M | -21.58%-756.49M | -35.20%-422.69M | -14.73%-622.21M | -36.12%-312.64M | -78.68%-542.32M | -82.32%-229.67M | -68.67%-303.52M | -32.33%-125.98M |
| Operating expenses | 14.34%-647.98M | 3.55%-407.69M | -21.58%-756.49M | -35.20%-422.69M | -14.73%-622.21M | -36.12%-312.64M | -78.68%-542.32M | -82.32%-229.67M | -68.67%-303.52M | -32.33%-125.98M |
| Gross profit | 11.31%700.77M | -22.91%318.35M | -45.61%629.59M | -35.56%412.97M | 13.41%1.16B | 16.08%640.84M | 21.93%1.02B | 57.10%552.09M | 41.37%837.05M | 20.36%351.42M |
| Selling expenses | 41.72%-260.31M | 50.77%-128.56M | -31.14%-446.65M | -101.36%-261.13M | 37.36%-340.59M | 40.14%-129.68M | -80.61%-543.72M | -221.23%-216.63M | -149.03%-301.04M | -25.84%-67.44M |
| Administrative expenses | 6.26%-199.84M | 9.32%-60.42M | 45.04%-213.18M | 54.47%-66.64M | -76.26%-387.9M | -61.67%-146.36M | -140.18%-220.08M | -283.70%-90.53M | -69.74%-91.63M | 6.06%-23.59M |
| Research and development expenses | 36.42%-46.43M | 38.48%-35.22M | ---73.04M | ---57.25M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | 8.13%-61.82M | -445.35%-34.28M | -1,841.93%-67.29M | ---6.29M | 35.67%-3.47M | ---- | ---5.39M | ---- | ---- | ---- |
| -Other impairment is provision | 8.13%-61.82M | -445.35%-34.28M | -1,841.93%-67.29M | ---6.29M | 35.67%-3.47M | ---- | ---5.39M | ---- | ---- | ---- |
| Special items of operating profit | -64.39%37.06M | -70.52%10.57M | 80.63%104.06M | -37.47%35.87M | -22.09%57.61M | 150.70%57.37M | 1,023.30%73.95M | 60.69%22.88M | -86.13%6.58M | -55.57%14.24M |
| Operating profit | 354.74%169.42M | 22.44%70.45M | -113.77%-66.51M | -86.37%57.53M | 48.47%483.11M | 57.64%422.16M | -27.85%325.39M | -2.48%267.81M | -2.95%450.96M | 11.95%274.63M |
| Financing cost | 13.12%-914K | 29.41%-444K | -3.54%-1.05M | 19.97%-629K | 28.85%-1.02M | 0.00%-786K | -68.20%-1.43M | -170.10%-786K | -7.20%-849K | 34.31%-291K |
| Share of profits of associates | 38.86%-15.32M | 97.92%-310K | -297.64%-25.06M | -180.74%-14.93M | -69.05%12.68M | -24.72%18.49M | 49.98%40.97M | 30.88%24.56M | 921.65%27.32M | --18.76M |
| Share of profit from joint venture company | -402.80%-25.47M | -391.35%-4.72M | -2,594.15%-5.07M | ---960K | -2,585.71%-188K | ---- | ---7K | ---- | ---- | ---- |
| Special items of earning before tax | -229.96%-7.99M | -221.82%-2.2M | -5.58%6.14M | -107.10%-683K | -41.11%6.51M | --9.62M | --11.05M | ---- | ---- | ---- |
| Earning before tax | 230.80%119.73M | 55.65%62.78M | -118.27%-91.54M | -91.03%40.33M | 33.28%501.1M | 54.15%449.48M | -21.25%375.98M | -0.52%291.58M | 3.66%477.43M | 18.46%293.1M |
| Tax | -357.69%-39.48M | -39.69%-9.31M | 125.27%15.32M | 85.80%-6.66M | -130.29%-60.63M | -69.67%-46.93M | 59.91%-26.33M | 29.55%-27.66M | 6.91%-65.67M | 14.09%-39.26M |
| After-tax profit from continuing operations | 205.29%80.25M | 58.80%53.47M | -117.30%-76.22M | -91.64%33.67M | 25.97%440.47M | 52.53%402.56M | -15.08%349.65M | 3.97%263.92M | 5.57%411.76M | 25.84%253.84M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | 31.08%116.03M | 106.29%116.03M | --88.52M | --56.25M |
| Special items of earning after tax | ---- | ---- | ---- | ---- | ---- | ---- | 31.08%116.03M | 106.29%116.03M | --88.52M | --56.25M |
| Earning after tax | 205.29%80.25M | 58.80%53.47M | -117.30%-76.22M | -91.64%33.67M | -5.41%440.47M | 5.95%402.56M | -6.91%465.68M | 22.53%379.96M | 28.27%500.28M | 53.72%310.09M |
| Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---610K |
| Minority profit | 1,131.46%21.11M | 183.94%16.07M | -157.92%-2.05M | -22.07%5.66M | 766.18%3.53M | 2,211.63%7.26M | 193.36%408K | 43.61%-344K | 43.76%-437K | ---610K |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | -15.27%349.24M | 3.86%264.27M | --412.19M | --254.45M |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | 31.08%116.03M | 106.29%116.03M | --88.52M | --56.25M |
| Profit attributable to shareholders | 179.73%59.14M | 33.51%37.4M | -116.98%-74.17M | -92.91%28.01M | -6.09%436.94M | 3.94%395.29M | -7.08%465.27M | 22.40%380.3M | 28.12%500.71M | 54.03%310.7M |
| Basic earnings per share | 181.65%0.0485 | 36.77%0.0305 | -117.12%-0.0594 | -92.80%0.0223 | -6.80%0.347 | 1.37%0.3098 | -6.39%0.3723 | 22.63%0.3056 | 26.66%0.3977 | 53.54%0.2492 |
| Diluted earnings per share | 181.65%0.0485 | 36.77%0.0305 | -117.19%-0.0594 | -92.74%0.0223 | -5.94%0.3455 | 1.82%0.3073 | -5.65%0.3673 | 24.61%0.3018 | 26.52%0.3893 | 50.72%0.2422 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.